Parliamentary Search

Written question asked by Lord Kamall (Conservative) on Thursday, 25 June 2026, in the House of Lords. It was due for an answer on Thursday, 9 July 2026. It was answered by Baroness Merron (Labour) on Monday, 6 July 2026 on behalf of the Department of Health and Social Care.

Brain: Tumours

Question

To ask His Majesty's Government whether the Department of Health and Social Care plans to collect data on the number of brain tumour patients receiving whole genome sequencing.

Answer

NHS England is responsible for commissioning the NHS Genomic Medicine Service (GMS) which provides genomic testing in the National Health Service in England, through a network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory, which includes tests for over 7,000 rare diseases and over 200 cancer clinical indications, including both whole genome sequencing (WGS) and non-WGS testing.

WGS for brain cancer is available under the National Genomic Test Directory under the GT1432 Test Code.

NHS England publishes testing activity and performance data through Patient Level Contract Monitoring data across all seven NHS GLHs on the NHS.UK website.

Secondary information

Type
Written question
Reference
HL1352
Session
2026-27
Subjects
Brain Tumours Genomics
Link
View this Written question on www.parliament.uk